REVISTA DE REUMATOLOGÍA
236. McMurray RW, Keiller D, Izui S, Hoffman RW, Walker SE. Postpartum (PP) disease activity in the female B/W mouse model of SLE (abstr). Arthritis Rheum 1991; 34: S163.
237. Lavalle C, Loyo E, Paniagua R, Bermúdez JA, Graef A, González Bárcena D, Fraga A: Correlation study between prolactin and androngens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268 -272.
238. Walker S, Jara L. Special Issue Prolactin In SLE. Lupus 1998; 7: 371-427.
239. Medina F, Ayala A, Jara L, Becerra Magdalena, Miranda JM, Fraga A. Acute abdomen in systemic lupus erythematosus: The importance of early laparatomy. Am J Med 1997; 102: 100-105.
240. Herrera Esparza R, Avalos Díaz E, Moreno Rodríguez J. Biología de los anticuerpos antinucleares. Universidad Autónoma de Zacatecas. Impreso en México 1997.
241. Bori Segura G. Principales enfermedades reumáticas en México. Aspectos epidemiológicos e impacto socioeconómico. Rev Mex Reumatol 2000,15: 183-201.
242. Castillo J, Naranjo A, Peña A, et al. Mortalidad por lupus eritematoso, experiencia de 44 años Rev Mex Reumatol 1989; 4(1): 6 (No.16).
243. Amigo MC, García Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.
244. Amigo MC, Khamashta MA. Antiphospholipid Hughes Syndrome in systemic lupus erythematosus. Rheumatic Dis Clinics North Amer 2000; 26: 331-348.
245. Amigo MC, García Torres R. Kidney disease in antiphospholipid syndrome. In: Hughes syndrome MA, Khamashta Editor. Springer. London, 2000 pp 70-81.
246. Miranda JM, García Torres R, Lara LJ, Medina F, Cerbera H, Fraga A. Renal biopsy of systemic lupus erythematosus: Significance of glomerular thrombosis analyces of 108 cases. Lupus 1994; 3: 25-29.
247. Alarcón Segovia D, Tumlin J, Furie R, Mc Kay J, Cardiel M, Linnik M, Hepburn B. SLE Trial shows fewer renal falres in L JP 394- treated patients with high affinity antibodies to LJP 394: 90 or trial results. Lupus 2001; 10(suppl): S 94.
248. Plunkett ML, Iverson GM, Crisologo J et al. L PJ 394: A novel clinical candidate for the treatment of lupus nephritis. Lupus 1995; 4: 99-103.
249. Weisman MH, Bluestein HG, Berner CM, de Haan HA. Reduction in circulatin dsDNA antibody titer after administration of lup 394 J. Rheumatol 1997; 24: 314-317.
250. Leaños Miranda A, Chávez _ Rueda KA, Blanco- Favela F. Biologic activity and plasma clearance of prolactin IgG complex in patients with systemic lupus erythematosus. Arthritis Rheumat 2001; 44: 866-875.
251.
Leaños
Miranda A, Pascoe D, Fraga A, Blanco
Favela. Anti-prolactin autoantibodies in systemic lupus
erythematosus patients with associated hyperprolactinemia.
Lupus 1998; 7: 398-403.
251A. Sánchez -Guerrero J, González-Pérez M, Durán
Carbajal M, Lara-Reyes P, Bahena-Amezcua S, Gravioto MC.
Effect of hormone replacement therapy (HRT) on disease activity
in postmenopausal patients with SLE. Arthritis Rheum
2001; 449 Supple. Abstract 1261. pp S 263.
252. Abadí I, González H. Epidemiología del lupus eritematoso sistémico, la experiencia venezolana. Rev Asoc Colomb de Rheum 1999; anuario; 17-22.
253. Reginato A S, Falasca G F. Connective tissue diseases in latin America 55 th Annual meeting of the American college of Reumatologia Boston 1991.
254. Venezuela's network of Rheumatic Disease units grew from master plan for Geographic Coverage of Nation PANLAR. Bulletin Vol. 7 No 2.
255. Abadí A I , González M N. Epidemiología del lupus eritematoso sistémico en Venezuela. Archivos de Reumatología 1993; 4(1): 8-15.
256. Brundula V, Rivas,Blasini AM, París M, Salazar S, Stekman IL, Rodríguez MA. Diminished level of T cell receptor chains in peripheral blood T lymphocytes from patients with Systemic lupus erythematosus. Arthritis Rheumatism 1999; 42: 1908-1914.
257. Blisini Ana M, Brundula V, París M, Rivas L. Salazar S, Stekman IL, Rodriguez MA. Protein Tyrosine Kinase activity in Lymphocytes from patients with systemic lupus erythematosus. J Autoimmunity 1998; 11: 387-393.
258. Blasini AM, Alonso E, Chacón R, Riera R, Steckman IL, Rodriguez MA. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T. Lymphocytes from patients with systemic lupus erythematosus. Lupus 1998; 7: 515-523.
259. Cifarelli DF, Placires F, Blasini AM, Alonso G, Rodríguez MA. Defective coupling of signaling molecules to the adaptes protein Grb2 in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Submitted.
260. Malavé I, Layrisee Z, Layrisse M. Dose-dependent hyporreactivity to phythohemagglutinin in systemic lupus erythematosus. Cell immunol 1975; 15: 231.
261. Defreitas ME, Kondracki E, Pérez-Rojas G, Bianco NE. Further aspects of T cell function in systemic lupus erytematosus, Immunol Commun 1982; 11: 113.
262. Rieber M, Contreras CE, Rieber MS, Bianco NE. Novel DNA-protein complex and a large DNA in SLE cryoprecipitates. Clin Exp Immunol 1986; 66: 61.
263. Contreras CE, Rieber MS, Bianco NE, Rieber M. Human repetitive and unique sequences coexist in a large circulating DNA species found in cryoprecipitates from SLE patients. Clin Exp Immunol 1988; 71: 73.
264. Stekman IL, Blasini AM, Leon-Ponté M, Baroja ML, Abadí I, Rodriguez MA. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum 1991; 31: 159.
265.
Rodríguez MA, Stekman IL, Blasini AM et al. Augmented
IL-2R expression and IL-2 responsiveness by T-lymphocytes activated via the CD3 complex in patients
with systemic lupus erythematosus. Arthritis Rheum 1990;
33: S128.
265A. Delgado MB, Blasini AM, González N, et al.
Polimorfismo en la longitud de los fragmentos de restricción para el
gen de la región constante de la cadena lambda de
inmunoglobulina en pacientes con lupus eritematoso sistémico.
Acta Cient Ven 1990; 41: 209.
266. Bettiol A, Esteva ME, Vivas J. Manifestaciones cardiovasculares en pacientes con lupus eritematoso sistémico. Archivos de Reumatología 1996; 7: 29-35.
267. Brundula V, Rivas L, Blasini AM, Paris M, et al Diminished levels of TCR zeta-chains in peripheral blood systemic lupys erythematosus (SLE). Lupus 1998; 7 (suppl 1): 68.
268. Tápanes FJ, Vásquez M, Ramírez R, Matheus C, Rodríguez MA, Bianco N. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropaty: are anti-extractable nuclear antibodies protective? Lupus 2000; 9: 437-444.
269. Cath cart ES, Scheinberg MA, Idelson BA, Couser WG. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet 1976; 1: 163-172.
270. Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J Exp Med 1985; 162 - 459-467.
271. Bonfá E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med: 1987; 317: 265-271.
272. Bonfá E, Chu JL, Brot Elkon KB. Lupus anti-ribosomal P peptide antibodies show limited heteregeneity and are predominantly of the IgG1 and IgG2 subclasses. Clin Immunol Immunopathol; 1987; 45: 129-138.
273. Elkon K; Bonfa E; Skelly S; Weissbach H; Brot N. Ribosomal protein autoantibodies in systemic lupus erythematosus. Bioessays 1987; 7: 258-261.
274. Bonfá E; Llovet R; Scheinberg M; de Souza JM; Elkon KB, Comparison between autoantibodies in malaria and leprosy with lupus. Clin Exp Immunol; 1987; 70: 529-537.
275. Bonfá E, Marshak Rothstein A, Wessbach H, Brot N, Elkon K. Frequency and epitope recognition of anti-ribosome P antibodies from humans with systemic lupus erythematosus and MRL/lpr mice are similar. J Immunol 1988; 140: 3434-3437.
276. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci USA 1988; 85: 5186-9.
277. Elkon KB, Bonfa E; Llovet R, Eisenberg RA. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J Immunol 1989; 143: 1549-1554.
278. Bonfá E, Parnassa AP, Rhoads DD, Roufa DJ, Wool IG, Elkon KB. Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1252-1261.
279. Viana VS, García S, Nascimento JH, Elkon KB; Brot N, Campos de Carvalho AC, Bonfa E. Induction of in vitro Herat block is not restricted to affinity purified anti-52 KDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 1998; 7: 141-147.
280. Elkon KB, Bonfá E, Weissbach H, Brot N. Antiribosomal antibodies in SLE infection, and following deliberate immunization. Adv Exp Med Biol 1994; 347: 81-92.
281. Bonfá E, Gaburo Junior N, Tavares AV, Cossermelli W. Comparison of five methods for the detection of antiribosomal P protein antibody. Braz J Med Biol Res 1994; 27: 637-643.
282. Elkon KB, Bonfá E, Brot N. Antiribosomal antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 877-890.
283. García S; Nascimento JH, Bonfá E, Levy R, Oliveira SF, Tavares AV, de Carvalho AC. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA positive patients in rabbit hearts. J Clin Invest 1994; 93: 718-724.
284. Bonfá E, Tavares AV, Viana VS, Levy-Neto M, Kumeda CA, Cossermelli W. Antibodies to new cytoplasmic autoantigens: anti-JA, a potencial marker for disease activity in systemic lupus erythematosus. Braz J Med Biol Res 1992; 25: 601-609.
285. Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfá E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 1999; 26: 1087-1093.
286. Bonfá E, Llovet R, Elkon K. Immunoblot análisis of IgG subclases of multiple lupus autoantibodies. J Immunol 1988 Apr 1; 140(7): 2231-2236.
287. Lockshin MD, Bonfá E, Elkon K, Druzin ML. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus (published erratum appears in Arthritis Rheum 1988 Sep; 31(9): 1203). Arthritis Rheum 1988; 31(6): 697-701.
288. Borba EF, Bonfá E. Dyslipoproteinemias in systemic lupus erythematosus: influence of dissease, activity, and anticardiolipin antibodies. Lupus 1997; 6: 533-540.
289. Borba EF, Santos RD, Bonfá E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhao RC. Lipoprotein(a) levels in systemic lupus erythematosus (see comments). J Rheumatol 21(2): 220-3, 1994 Feb. Comment in: /J Rheumatol/1996; 23: 194-196.
290. Borba EF, Bonfá E, Longterm beneficial effect of chlroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. J Rheumatol 2001; 28: 780-785.
291. Atra E, Sato El. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 1993; 11: 487-493.
292. Sato EI; Assis LS, Lourenzi VP, Andrade LE. Long _ term thalidomide use in refractory cutaneous lesions of systemic lupus erythematosus. Rev Assoc Med Bras 1988; 44: 289-293.
293. Cameiro JR, Sato EI. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1999; 26: 1275-1279.
294. Meinao IM, Sato EI, Andrade LE, Ferraz MB, Atra E. Division of Rheumatology, Escola Paulista de Medicina Universidade Federal de Sao Paulo, Brazil. Lupus 1996; 5: 237-244.
295. Sato EI, Atra E, Gabriel A Jr, Masi AT. Systemic lupus erythematosus: a family study of 25 probands. Clin Exp Rheumatol 1991; 9: 455-461.
296. Araújo MN, Silva NP, Andrade LE, Sato EI, Gerbase _ DeLima M, Leser PG. C2 deficiency in blood donors and lupus patients: prevalence clinical characteristics and HLA-associations in the Brazilian population. Lupus 1997; 6: 462-466.
297. Chahade WH, Sato EI, Moura JE Jr, Costallat LT, Andrade LE. Systemic lupus erythematosus in Sao Paulo/Brazil: a clinical and laboratory overview 1995; 4: 100-103.
298. Costallat LT, Coimbra AM. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol; 1994; 12: 603-607.
299. Costallat LT, Quagliato EM, Zanardi VA. Evoked potentials in the assessment of neuropsychiatric manifestations in systemic lupus erythematosus (setter). Clin Rheumatol: 1997; 16: 217-219.
300. Lorand-Metze I, Carvalho MA, Costallat LT. Morphologie des knochenmarks bei systemischen Lupus erythematodes. Pathologe 1994; 15: 292-296.
301. Marini R, Costallat LT. Young age at onset, renal involvement and arterial hypertension are of adverse prognostic significance in juvenille systemic lupus erythematosus. Rev Rheum Engl 1999; 66: 303-309.
302. Costallat LT, Ribeiro CC, Annichino _ Bizzacchi JM. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus. Sangre 1998; 43: 345-348.
303. Vilarinho ST, Costallat LT. Evaluation of the hypothalmic _ pitituary _ gonadal axis in males with systemic lupus erythematosus (see comments). J Rheumatol 1998; 25: 1097-1103.
304. Cannavan FP, Costallat LT, Bertolo MB, Rossi CL, Costa SC. False positive IgM antibody tests for human cytomegalovirus (HCMV) in patients with SLE (letter). Lupus 1998; 7: 61-62.
305. Costallat LT, Coimbra AM. Systemic lupus erythematosus in 18 Brazilian males: clinical and laboratory analysis. Clin Rheumatol 1993; 12: 522-525.
306. Costallat LT, de Oliveira RM, Santiago MB, Cossermelli W, Samara AM. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin Rheumatol 1990; 9: 489-497.
307. Santiago MB, Viana V, Bueno C, Yoshinari N, de Oliveira RM. Cossermelli W. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo 1990; 45: 167-170.
308. De Oliveira RM, Bueno C, Viana VS, Yoshinari NH, Cossermelli W, Santiago MB. Association of anti-DNA and anticardiolipin antibodies in systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo 1989; 44: 73-75.
309. Dos Santos RF, Santiago MB, Yoshinari NH, Rodrígues CJ, Cossermelli W. Teste cutaneo de imunofluorescencia direta no lupus eritematosos sistemic. Correlaçao com estadio clinico da doença, alteraçoes laboratoriais e nefropatia. Rev Hosp. Clin Fac Med Sao Paulo 1988; 43: 197-200.
310. Pereira RM, Santiago MB, Yoshinari NH. Lupus eritematoso sistemico em crianzas (LES). Rev Hosp. Clin Fac Med Sao Paulo 1987; 42: 155-158.
311. Santiago MB, Pereira RM, Yoshinari NH, de Mendoza EC. Lupus eritematoso sistémico no sexo masculino. Rev Hosp Clin Fac Med Sao Paulo 1986; 41: 121-123.
312. Chapira EP, Cassia Sucena R, Carrazai AM, Scheinberg MA. A Historia Natural do lupus eritematoso sistémico: experiencia do Instituto do Cancer "Arnaldo Vieira de Carvalho". Rev Paul Med 1990; 108: 17-22.
313. Pons Estel B, Alarcón Segovia D. ¿Qué sabemos del lupus en Latinoamérica? Creación de una cohorte multinacional por el grupo latinoamericano del estudio del lupus Gladel. Revista Mexicana de Reumatología 2001; 16: 105-108.